European Archives - Page 476 of 1166 - European Medical Journal

Interview: Louise Dyson

EMJ spoke to Louise Dyson about systematic non-adherence to mass drug administration, modelling to support the eradication of NTDs, and more.

ROI in R&D declines sharply in 2022

Projected pharmaceutical R&D return on investment has hit its lowest level for 13 years, according to a new report by Deloitte.

Spotlight: December 2022 - January 2023

GOLD looks back at some of the pharma industry’s recent news.

A blockchain solution for pharma

How can blockchain-based technology advance business development and investment?

Behind the Scenes of Healthcare

Bruce Gewertz joins Jonathan in this episode of the EMJ Podcast to discuss work-life balance in medicine and the steps to optimising leadership

RSV drug nirsevimab chases FDA approval

A drug to treat infants with RSV is on its pathway to approval in the US following a successful Biologics License Application to the FDA.

Robotic PCI: Technology Overview, New Clinical Evidence, and Future Possibilities

This webinar explores robotic percutaneous coronary intervention (PCI). Constantin von zur Mühlen, University Heart Center Freiburg, Bad Krozingen, Germany, will discuss the establishment of robotic-assisted PCI in Europe, its challenges, and opportunities at a tertiary referral centre.

5 minutes with Gen Li, President, Phesi

5 minutes with Gen Li, President of clinical trial database company Phesi.

Wound Healing in a Time of Antimicrobial Resistance

Karen Ousey joins Jonathan Sackier on this episode of the EMJ Podcast to discuss antimicrobial resistance and wound healing.

Editor's Letter: December 2022

Pharma should double down on its patient centricity efforts to help tackle inequalities in 2023 and beyond, says Helena Beer.